To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.
Find out MoreTIDM | HYG |
---|---|
Ticker Code | HYG.L |
ISIN | GB0031256109 |
Currency | GBX |
Issue Country | GB |
Sector | NMX302040 |
Year End | 31-Dec-22 |
Shares in Issue | 31.00m |
---|---|
Market Cap. | £4.19m |
Market Size | 1 |
PE Ratio | -0.813253 |
Earnings | -16.60 |
Dividend | 2.00 |
Yield | 14.815% |
# of Trades | 0 |
---|---|
Vol Sold | 0 |
Vol Bought | 0 |
52 Week High | 22.50 |
52 Week High Date | 03-May-2023 |
52 Week Low | 13.00 |
52 Week Low Date | 19-Oct-2023 |
Standard | GAAP | GAAP | GAAP | GAAP | GAAP |
---|---|---|---|---|---|
Millions | Millions | Millions | Millions | Millions | |
Income Statement | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 | 31 Dec '18 |
Turnover | n/a | n/a | n/a | n/a | n/a |
Operating Profit / Loss | (0.03) | (0.02) | n/a | n/a | (0.06) |
Net Interest | n/a | n/a | n/a | n/a | n/a |
Pre Tax Profit | (0.03) | (0.02) | n/a | n/a | (0.06) |
Post Tax Profit | (0.03) | (0.02) | n/a | n/a | (0.06) |
Continuing EPS | |||||
Earnings per Share (Basic) | n/a | n/a | n/a | n/a | n/a |
Earnings per Share (Diluted) | n/a | n/a | n/a | n/a | n/a |
Earnings per Share (Adjusted) | n/a | n/a | n/a | n/a | n/a |
Continuing and Discontinued EPS | |||||
Earnings per Share (Basic) | (0.30p) | (0.20p) | n/a | n/a | (0.70p) |
Earnings per Share (Diluted) | (0.30p) | (0.20p) | n/a | n/a | (0.70p) |
Earnings per Share (Adjusted) | (0.30p) | (0.20p) | n/a | n/a | (0.70p) |
Dividend per Share | 2.00p | 4.00p | 13.00p | 18.00p | 10.00p |
Millions | Millions | Millions | Millions | Millions | |
Balance Sheet | 31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 | 31 Dec '18 |
Non-Current Assets | |||||
Intangible Assets | n/a | n/a | n/a | n/a | n/a |
Tangible Assets | n/a | n/a | n/a | n/a | n/a |
Fixed Investments | 2.97 | 3.21 | 2.14 | 2.07 | 2.79 |
Total Fixed Assets | 2.97 | 3.21 | 2.14 | 2.07 | 2.79 |
Current Assets | |||||
Stocks | n/a | n/a | n/a | n/a | n/a |
Debtors | n/a | n/a | n/a | n/a | n/a |
Cash at Bank and in Hand | 0.41 | 0.32 | 0.53 | 0.47 | 2.74 |
Total Assets | 3.38 | 3.53 | 2.67 | 2.54 | 5.53 |
Current Liabilities | |||||
Creditors Within 1Yr | 0.02 | 0.02 | 0.02 | 0.02 | 0.06 |
Net Current Assets | 0.39 | 0.30 | 0.51 | 0.45 | 2.68 |
Non-Current Liabilities | |||||
Creditors After 1Yr | 0.35 | 0.35 | 0.19 | 0.05 | 0.19 |
Net Assets | 3.01 | 3.16 | 2.45 | 2.46 | 5.28 |
Capital and Reserves | |||||
Called Up Share Capital | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
Share Premium Account | n/a | n/a | n/a | n/a | n/a |
Other Reserves | 4.92 | 5.04 | 4.32 | 4.33 | 7.15 |
Shareholders Funds | 3.01 | 3.16 | 2.45 | 2.46 | 5.28 |
Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
31 Dec '22 | 31 Dec '21 | 31 Dec '20 | 31 Dec '19 | 31 Dec '18 | |
Operating Margin | n/a | n/a | n/a | n/a | n/a |
Return on Capital Employed | n/a | n/a | n/a | n/a | n/a |
Dividend Cover | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | 33.30 | n/a | n/a |
PE Ratio | n/a | n/a | n/a | n/a | n/a |
PEG | n/a | n/a | n/a | n/a | n/a |
Dividend per Share Growth | n/a | n/a | n/a | n/a | n/a |
Net Asset Value per Share | 37.06p | 38.90p | 30.23p | 30.35p | 65.09p |